Document is current

Any future updates will be listed below

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme

Crossref DOI link: https://doi.org/10.1007/s13300-019-00736-6

Published Online: 2019-12-12

Published Print: 2020-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark